Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Filings indexed 129 across all filing types
Latest filing 2024-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 팜스빌' (Pharmsville Co., Ltd.) covering the period from January 1, 2024, to September 30, 2024. It contains detailed company information, business overview, capital structure, and management details, which are characteristic of a formal quarterly financial report. It is not a short announcement or a certification letter, but the full report itself. 9M 2024
2024-11-14 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Pharmsville' (주식회사 팜스빌) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial and operational information, including company overview, business activities, and capital structure. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim/Quarterly Report (IR). H1 2024
2024-08-13 Korean
불성실공시법인미지정 (지정유예)
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement from the KOSDAQ market regarding the status of a company (Farmsville) as a 'non-designated' entity for unfair disclosure. It details the regulatory decision, the grounds for the decision (KOSDAQ disclosure regulations), and the specific conditions for the deferral of the designation. Since this is a formal regulatory notice regarding compliance and disclosure status that does not fit into specific categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2024-07-22 Korean
불성실공시법인지정예고 (공시불이행)
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange regarding the designation of 'Farmsville' as an 'unfaithful disclosure corporation' due to failure to disclose significant changes in revenue or profit structure. This is a regulatory announcement concerning compliance and potential penalties, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2024-07-10 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from the Korea Exchange regarding a change in the company's industry classification code due to a revision in the Korean Standard Industrial Classification. It does not fit into specific financial reporting categories like 10-K, IR, or ER, and is not a report publication announcement. Therefore, it falls under the general regulatory filing category.
2024-06-28 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Pharmsville' (주식회사 팜스빌) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial and operational information, including company overview, business activities, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.